Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - Discussion

17 March 2019 (14:25 - 14:30)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Jose Luis Merino

La Paz University Hospital, Madrid (Spain)

10 More presentations in this session

Presentation thumbnail

A randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation:The CIRCA-DOSE Study

Doctor J. Andrade (Vancouver, CA)

Presentation thumbnail

CIRCA-DOSE Study - Discussion

Professor D. Scherr (Graz, AT)

Presentation thumbnail

Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - AVATAR AF

Professor P. Kanagaratnam (London, GB)

Presentation thumbnail

Quality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation catheter: results from the multicenter GOLD AF registry

Professor L. Boersma (Nieuwegein, NL)

Presentation thumbnail

GOLD AF registry - Discussion

Access the full session

Session thumbnail

Late-breaking trials 1

The Event

EHRA 2019

17 March 2019 14:25 CET

You may be interested in

Congress Session

Update on antiarrhythmic therapy

31 March 2025

Congress Presentation

Early recurrence after pulsed field ablation as a potential predictor of late arrhythmia: a systematic review and meta-analysis

14 April 2026

Congress Presentation

Catheter ablation is associated with reduced all-cause mortality in a real-world cohort of patients with atrial fibrillation and heart failure

31 August 2019

Congress Session

Hot topics in electrophysiology

30 March 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources